Covalon Technologies (CVE:COV) Trading 1% Higher

Shares of Covalon Technologies Ltd. (CVE:COVGet Free Report) traded up 1% during mid-day trading on Thursday . The company traded as high as C$2.05 and last traded at C$2.05. 5,000 shares were traded during mid-day trading, a decline of 52% from the average session volume of 10,412 shares. The stock had previously closed at C$2.03.

Covalon Technologies Price Performance

The company has a market cap of C$50.57 million, a PE ratio of -10.79 and a beta of 0.52. The company has a debt-to-equity ratio of 7.79, a quick ratio of 6.45 and a current ratio of 4.81. The stock has a 50 day moving average of C$1.72 and a 200-day moving average of C$1.39.

Covalon Technologies (CVE:COVGet Free Report) last issued its earnings results on Wednesday, May 29th. The company reported C$0.06 earnings per share (EPS) for the quarter. The company had revenue of C$8.41 million during the quarter. Covalon Technologies had a negative return on equity of 23.98% and a negative net margin of 19.67%. Equities analysts predict that Covalon Technologies Ltd. will post 0.3 earnings per share for the current year.

Covalon Technologies Company Profile

(Get Free Report)

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.

Further Reading

Receive News & Ratings for Covalon Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies and related companies with MarketBeat.com's FREE daily email newsletter.